| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(91)93327-6 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0140673691933276?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0140673691933276?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1670647 |
| P2093 | author name string | R. A. Elton | |
| M. F. Oliver | |||
| D. A. Wood | |||
| K. F. Gey | |||
| R. A. Riemersma | |||
| C. C. Macintyre | |||
| P2860 | cites work | Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 |
| Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment | Q33610339 | ||
| Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia | Q34340579 | ||
| Probucol inhibits oxidative modification of low density lipoprotein | Q34522551 | ||
| Deprivation: explaining differences in mortality between Scotland and England and Wales | Q35717192 | ||
| Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids | Q36263522 | ||
| Selenium and vitamin E in relation to risk factors for coronary heart disease | Q37179675 | ||
| Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart | Q41380098 | ||
| Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease | Q43459666 | ||
| Effect of alpha-tocopherol on hypoxic-perfused and reoxygenated rabbit heart muscle | Q43924472 | ||
| Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease | Q44621395 | ||
| Concomitants of excess coronary deaths--major risk factor and lifestyle findings from 10,359 men and women in the Scottish Heart Health Study. | Q51618209 | ||
| Ischaemic-heart-disease mortality and dietary intake of calcium. | Q53710213 | ||
| Decline of coronary mortality in United States and vitamin C | Q66904307 | ||
| Vitamin A reserve of liver in health and coronary heart disease among ethnic groups in Singapore | Q68020302 | ||
| The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels | Q68090477 | ||
| Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men | Q68092393 | ||
| Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy | Q69383418 | ||
| Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden | Q69633328 | ||
| Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands | Q69740766 | ||
| Cigarette smoking, social class and nutrient intake: relevance to coronary heart disease | Q69840671 | ||
| The influence of smoking on vitamin C status in adults | Q69940981 | ||
| On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers | Q70856762 | ||
| Leukocyte ascorbic acid and its relationship to coronary artery disease in man | Q71347426 | ||
| Does consumption of fruit and vegetables protect against stroke? | Q72553580 | ||
| Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men | Q72582848 | ||
| P433 | issue | 8732 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-5 | |
| P577 | publication date | 1991-01-01 | |
| 1991-01-05 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene | |
| P478 | volume | 337 |
| Q73218003 | 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease |
| Q24804089 | A new automated method for the determination of the Total Antioxidant Capacity (TAC) of human plasma, based on the crocin bleaching assay |
| Q58071804 | Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men |
| Q41214587 | Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention |
| Q73224129 | Alpha- and beta-carotenes in low density lipoprotein are the preferred target for nitric oxide-induced oxidation |
| Q53744418 | Analysis of the antioxidant activity of 4-(5-chloro-2-hydroxyphenylamino)-4-oxobut-2-enoic acid derivatives using quantum-chemistry descriptors and molecular docking. |
| Q37354661 | Antiatherogenic effects of vitamin E: the search for the Holy Grail |
| Q73681898 | Antioxidant defence in recurrent abortion |
| Q42394158 | Antioxidant nutrients, atherosclerosis, and coronary heart disease |
| Q33602930 | Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease |
| Q71847563 | Antioxidant status of hypercholesterolemic patients treated with LDL apheresis |
| Q36270104 | Antioxidant supplements: Effects on disease and aging in the United States population |
| Q33748019 | Antioxidant vitamin supplements: update of their potential benefits and possible risks |
| Q46207508 | Antioxidant vitamins and coronary artery disease risk in South African males. |
| Q32062421 | Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data |
| Q34107501 | Antioxidants and vitamins to reduce cardiovascular disease |
| Q40928840 | Antioxidants in cardiovascular disease: randomized trials |
| Q34186079 | Antioxidants in health and disease. |
| Q41154173 | Antioxidants, atherosclerosis and thrombosis. |
| Q73486872 | Ascorbic Acid Inhibits Lipid Peroxidation but Enhances DNA Damage in Rat Liver Nuclei Incubated with Iron Ions |
| Q72315535 | Ascorbic acid can either increase or decrease low density lipoprotein modification |
| Q92409292 | Assessment of the Antioxidant/Hypolipidemic Relationship of Sideritis hyssopifolia in an Experimental Animal Model |
| Q73693823 | Beta-carotene and protein oxidation: effects of ascorbic acid and alpha-tocopherol |
| Q33770484 | Beta-carotene and risk of coronary heart disease. A review of observational and intervention studies |
| Q57561168 | Beta-carotene intake and risk of nonfatal acute myocardial infarction in women |
| Q34006297 | Bioactive phospholipid oxidation products |
| Q44336171 | Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. |
| Q41154272 | Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system |
| Q41156028 | Cancer risk and oxidative DNA damage in man. |
| Q36678894 | Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants |
| Q36524655 | Carotenoids and total phenolic contents in plant foods commonly consumed in Korea |
| Q73637136 | Characterization of antioxidants present in hawthorn fruits |
| Q34278783 | Chronic heart failure and micronutrients |
| Q33731277 | Chronic progressive motor polyneuropathy after ganglioside treatment |
| Q40439840 | Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? |
| Q40795448 | Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects |
| Q72610994 | Coenzyme Q10 and coronary artery disease |
| Q77164616 | Comparison of glycoprotein components, tryptophan, lipid peroxidation and antioxidants in borderline and severe hypertension and myocardial infarction |
| Q33673516 | Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease |
| Q42276864 | Copper-Induced Tissue Factor Expression in Human Monocytic THP-1 Cells and Its Inhibition by Antioxidants |
| Q71060520 | Coronary heart disease and vitamin E |
| Q34185229 | Coronary heart disease prevention: nutrients, foods, and dietary patterns |
| Q44505661 | Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease |
| Q43671483 | Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer |
| Q33834133 | Dietary antioxidants and cardiovascular disease |
| Q39369790 | Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects |
| Q72351199 | Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients hospitalized with acute myocardial infarction |
| Q73815128 | Effect of trilinolein on the activity and gene expression of superoxide dismutase in cultured rat brain astrocytes |
| Q46187066 | Effect of vitamin E on the anticoagulant response to warfarin |
| Q34345963 | Effects of ACE inhibitors on oxidation of human low density lipoprotein |
| Q35367545 | Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris |
| Q64889953 | Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux. |
| Q58317016 | Effects of lisinopril and amlodipine on antioxidant status in experimental hypertension |
| Q77684283 | Effects of postprandial hyperlipemia on the vitamin E content of lipoproteins. GERBAP section Lipoprotéines. Groupe d'Evaluation et de Recherche de l'Assistance Publique des Hôpitaux de Paris |
| Q73232083 | Effects of vitamin E on human platelet and mononuclear cell responses in vitro |
| Q54129425 | Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men. |
| Q73295124 | Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients |
| Q48467349 | Evaluation of biological effects induced by diagnostic ultrasound in the rat foetal tissues |
| Q33695142 | Fatty acids, antioxidants, and coronary heart disease from an epidemiological perspective |
| Q40886414 | Free radical involvement in aging. Pathophysiology and therapeutic implications |
| Q59353799 | Fuentes Alimentarias de Vitaminas A, C, E y Beta-caroteno en una Población adulta Mediterránea |
| Q73141469 | High plasma levels of alpha- and beta-carotene are associated with a lower risk of atherosclerosis: results from the Bruneck study |
| Q73572439 | In situ kinetics: an approach to recommended intake of vitamin C |
| Q79369236 | Increased plasma thioredoxin in patients with acute myocardial infarction |
| Q40561201 | Insights into the pathogenesis and prevention of coronary artery disease. |
| Q80991752 | Interaction between flavonoids and alpha-tocopherol in human low density lipoprotein |
| Q43151527 | Iron and coronary heart disease |
| Q37060343 | Iron, free radicals and cancer |
| Q37651509 | Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials |
| Q67994023 | Kinetics of photoperoxidation of arachidonic acid: molecular mechanisms and effects of antioxidants |
| Q44279285 | Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients |
| Q41682757 | Lipoprotein oxidation, antioxidants and cardiovascular risk: epidemiologic evidence |
| Q34798299 | Low dose colestipol in adolescents with familial hypercholesterolaemia |
| Q50893315 | Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. |
| Q34127841 | Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. |
| Q58421161 | MRC/BHF Heart Protection Study |
| Q42332637 | Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment |
| Q73914979 | Menopause |
| Q34204611 | Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. |
| Q73091616 | Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation |
| Q58863676 | Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells∗ |
| Q42643435 | Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease |
| Q38012354 | NADPH oxidases as therapeutic targets in ischemic stroke. |
| Q35375986 | NOX1, 2, 4, 5: counting out oxidative stress |
| Q40923118 | New approaches to the prevention of atherosclerosis |
| Q51990100 | Nutrition, ageing and ill health. |
| Q34015039 | Nutritional factors in stroke |
| Q36981763 | Nutritional supplements and conventional medicine; what should the physician know? |
| Q24561734 | Oxidants, antioxidants, and the degenerative diseases of aging |
| Q47987122 | Oxidation resistance of LDL is correlated with vitamin E status in beta-thalassemia intermedia. |
| Q36012153 | Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome |
| Q44524468 | Oxidative stress status in patients with diabetes mellitus: relationship to diet |
| Q33612896 | Oxidised low density lipoproteins and atherogenesis |
| Q40896295 | Oxidized LDL and antioxidants |
| Q33899039 | Pioneer research in Britain into atherosclerosis and coronary heart disease--an historical review |
| Q33908994 | Plasma antioxidants and longevity: a study on healthy centenarians. |
| Q87663139 | Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome |
| Q35401935 | Plasma vitamin C and food choice in the third Glasgow MONICA population survey |
| Q78815306 | Plasma vitamin E, total antioxidant status and vascular function in young adults |
| Q41092668 | Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study |
| Q40725177 | Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis |
| Q40541276 | Prospects for the use of antioxidant therapies |
| Q35820938 | Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up |
| Q71060539 | Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) |
| Q36902624 | Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants |
| Q36824725 | Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress, and development of experimental atherosclerosis: the diet and antioxidant trial on atherosclerosis (DATA). |
| Q37629328 | Regulatory metabolites of vitamin E and their putative relevance for atherogenesis |
| Q39539817 | Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. |
| Q41191897 | Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. |
| Q48587812 | Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study |
| Q28266553 | Seasonal and climatic variation in cholesterol and vitamin C: effect of vitamin C supplementation |
| Q78214221 | Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults: the Third National Health and Nutrition Examination Survey (NHANES III) |
| Q63812117 | Serum carotenoids and atherosclerosis |
| Q64130878 | Serum vitamins, carotenoids, and angina pectoris: findings from the National Health and Nutrition Examination Survey III |
| Q35582426 | Should antioxidant status be considered in interventional trials with antioxidants? |
| Q44341187 | Some histologic and biochemical evidence for mitigation of cyanide-induced tissue lesions by antioxidant vitamin administration in rabbits |
| Q37221904 | Synthesis and antioxidant activities of novel 5-chlorocurcumin, complemented by semiempirical calculations. |
| Q48573030 | The Boyd Orr lecture. Nutrition interventions in aging and age-associated disease |
| Q41333579 | The Leon Golberg Memorial Lecture. Antioxidants and disease prevention |
| Q37039914 | The Mediterranean Diet: Fish and Olives, Oil on Troubled Waters |
| Q35015123 | The Oxidative State of LDL is the Major Determinant of Anti/Prooxidant Effect of Coffee on Cu Catalysed Peroxidation |
| Q37358390 | The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium |
| Q71848030 | The in vitro antioxidant activity of trilinolein and other lipid-related natural substances as measured by enhanced chemiluminescence |
| Q74727297 | The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers |
| Q34214002 | The protective role of selenium on genetic damage and on cancer |
| Q41099877 | The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia |
| Q34319485 | The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease |
| Q35157613 | The role of vitamin E in atherosclerosis |
| Q61442776 | The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up |
| Q36904229 | The treatment of gall stones |
| Q34805200 | The use of antioxidant supplements in coronary heart disease |
| Q77988284 | Tissue damage in acute myocardial infarction: selective protection by vitamin E |
| Q50939704 | Ubiquinol-10 and total peroxyl radical trapping capacity of LDL lipoproteins during aging: the effects of Q-10 supplementation. |
| Q71015631 | Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) |
| Q47313489 | Using cluster analysis to examine dietary patterns: nutrient intakes, gender, and weight status differ across food pattern clusters |
| Q24524225 | Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet |
| Q37357656 | Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation |
| Q37367258 | Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking |
| Q24568279 | Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance |
| Q35657804 | Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo |
| Q72414750 | Vitamin E |
| Q48365151 | Vitamin E (α- and γ-Tocopherol) Levels in the Community: Distribution, Clinical and Biochemical Correlates, and Association with Dietary Patterns |
| Q42538178 | Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina |
| Q33828621 | Vitamin E and heart disease: basic science to clinical intervention trials |
| Q41533319 | Vitamin E and human health: rationale for determining recommended intake levels |
| Q54078862 | Vitamin E improves arterial compliance in middle-aged men and women. |
| Q40975886 | Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages |
| Q35308229 | Vitamin E status of 20- to 59-year-old adults living in the Seoul metropolitan area of South Korea |
| Q77429307 | Vitamin E supplementation attenuates myointimal proliferation of the abdominal aorta after balloon injury in diet-induced hypercholesterolemic rabbits |
| Q73701464 | Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL |
| Q37282850 | Vitamins and cardiovascular disease |
| Q73681262 | Where Are we with Vitamin E? |
| Q33607440 | Why are low-density lipoproteins atherogenic? |
| Q41522416 | Will the ‘Good Fairies’ Please Prove to us that Vitamin E Lessens Human Degenerative Disease? |
| Q73903824 | [Should antioxidants be recommended for the prevention of cardiovascular diseases?] |
| Q73038414 | [Vitamin E distribution of lipoproteins in patients with coronary heart disease] |
| Q72358603 | [Vitamin E, antioxidants and atherosclerosis] |
| Q33654586 | d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties |
| Q72276134 | gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets |
Search more.